Close

Boston Scientific To Participate In Canaccord Conference And Wedbush PacGrow Healthcare Conference

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...
Boston Scientific Corp is scheduled to participate in the 36th Annual Canaccord Genuity Growth Conference onAugust 11 in Boston and the 2016 Wedbush PacGrow Healthcare Conference on August 16 in New York.
Susie Lisa, vice president, and Justin Castelli, senior manager, Investor Relations, will participate in a 25-minute question-and-answer session with the Canaccord Genuity host analyst beginning at approximately 8:30 a.m. ET on August 11, and a 30-minute question-and-answer session with the Wedbush PacGrow host analyst beginning at approximately 10:20 a.m. ET on August 16.A replay of each webcast will be accessible at www.bostonscientific.com/investors  beginning approximately one hour following the completion of the event.
 
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com 
CONTACTS
Media:                          
Tom Keppeler                      
508-683-6585 (office)                 
Media Relations                       
Boston Scientific Corporation          
thomas.keppeler@bsci.com            
Investors:
Susie Lisa, CFA
508- 683-5565 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com

Latest stories

Related stories

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back